Advanced Biological Laboratories has granted Abbott non-exclusive rights to market ABL’s software suite for HIV genotyping data analysis.

Abbott will utilize its expertise in infectious disease diagnostics to offer ABL products for HIV genotyping, and facilitate access to the newest and up-to-date analysis of HIV genotyping to its customers in the United States.

For further deal information visit Current Agreements (subscription required)

Related

Report: Partnering Deals and Alliances with Abbott Labs

Report: HIV Partnering 2009-2014

View: Top 50 pharma – overview of top 50 pharmaceutical companies by revenue – partnering activity, deal news, partnering dealtalk

Browse: Complete Current Partnering report catalogue

View: Partnering Scorecard in CP Insight– view top life science partnering deals by value

View: DealMetrics in CP Insight – the latest deal trend infographics for life science deal making

View: CP Insight’s Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity

View: CP Insight’s Big Biotech Deal Making Scorecard – latest trends in big biotech deal making activity

Signup: Current Partnering Dealmakers Update – weekly newsletter providing the latest life science industry deal news, deal making trends, partnering events – sign up now

Signup: Current Agreements Deals Review – monthly newsletter – reviewing the previous month’s life science deal making – partnering, M&A and financing – sign up now

Subscribe: Current Agreements life sciences partnering, M&A and financing deals database – find out more

Follow us on: LinkedIn Current Partnering | LinkedIn Business Development Network | @Currentpartner on Twitter